These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16144508)

  • 1. Fluvastatin: efficacy and safety in reducing cardiac events.
    Chan MY; Lee CH
    Expert Opin Pharmacother; 2005 Sep; 6(11):1883-95. PubMed ID: 16144508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the lipid-related effects of fluvastatin.
    Liberopoulos EN; Daskalopoulou SS; Mikhailidis DP; Wierzbicki AS; Elisaf MS
    Curr Med Res Opin; 2005 Feb; 21(2):231-44. PubMed ID: 15801994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of fluvastatin in cardiovascular risk management.
    McDonald KJ; Jardine AG
    Expert Opin Pharmacother; 2008 Jun; 9(8):1407-14. PubMed ID: 18473714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
    Peters TK; Muratti EN; Mehra M
    Am J Med; 1994 Jun; 96(6A):79S-83S. PubMed ID: 8017471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB; Roth D
    Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 8. Saudi Arabia experience trial of fluvastatin (Lescol) in the treatment of hyperlipidemia.
    Galal MS; Abdel Wahed M; Salem KA
    J Egypt Public Health Assoc; 1997; 72(3-4):285-302. PubMed ID: 17216990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
    Farnier M; Dejager S
    Am J Cardiol; 2000 Jan; 85(1):53-7. PubMed ID: 11078237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL
    Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not just decreased LDL level is decisive. Which statin for patients at risk for coronary disease?].
    MMW Fortschr Med; 2004 Jun; 146(24):1-3. PubMed ID: 15366507
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study.
    Morishita R; Itakura H; Nakaya N; Yoshida M; Odawara M; Ichihara A; Mizuno K
    Curr Vasc Pharmacol; 2012 Mar; 10(2):178-86. PubMed ID: 21824105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P
    Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
    Plosker GL; Wagstaff AJ
    Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin: a review of its use in lipid disorders.
    Langtry HD; Markham A
    Drugs; 1999 Apr; 57(4):583-606. PubMed ID: 10235694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin titrate-to-goal clinical practice study.
    Weiss RJ
    Am J Ther; 1998 Sep; 5(5):281-5. PubMed ID: 10099070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
    Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.
    Bruckert E; Lièvre M; Giral P; Crepaldi G; Masana L; Vrolix M; Leitersdorf E; Dejager S
    Am J Geriatr Cardiol; 2003; 12(4):225-31. PubMed ID: 12888702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B; Benghozi R; Pfister P; Holmes D
    Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin.
    Lawrence JM; Reckless JP
    Expert Opin Pharmacother; 2002 Nov; 3(11):1631-41. PubMed ID: 12437496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.